These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
389 related items for PubMed ID: 19892236
1. Can natriuretic peptides help identify heart failure patients for whom statins are beneficial? Daniels LB, Barrett-Connor E. J Am Coll Cardiol; 2009 Nov 10; 54(20):1860-1. PubMed ID: 19892236 [No Abstract] [Full Text] [Related]
2. Rosuvastatin and cardiovascular continuum when time is important. Barrios V, Escobar C. J Am Coll Cardiol; 2010 Apr 13; 55(15):1645-6; author reply 1646. PubMed ID: 20378088 [No Abstract] [Full Text] [Related]
3. Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). Cleland JG, McMurray JJ, Kjekshus J, Cornel JH, Dunselman P, Fonseca C, Hjalmarson A, Korewicki J, Lindberg M, Ranjith N, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J, CORONA Study Group. J Am Coll Cardiol; 2009 Nov 10; 54(20):1850-9. PubMed ID: 19892235 [Abstract] [Full Text] [Related]
4. CORONA, statins, and heart failure: who lost the crown? Athyros VG, Kakafika AI, Tziomalos K, Karagiannis A, Mikhailidis DP. Angiology; 2008 Nov 10; 59(1):5-8. PubMed ID: 18319216 [No Abstract] [Full Text] [Related]
5. Controlled Rosuvastatin Multinational Trial In Heart Failure (the positive negative trial). Serebruany VL. Am J Cardiol; 2008 Jun 15; 101(12):1808-9. PubMed ID: 18549865 [No Abstract] [Full Text] [Related]
6. Stroke and anticoagulation in heart failure without atrial fibrillation: from risk to opportunity. Homma S, Ye S. Circulation; 2015 Apr 28; 131(17):1465-7. PubMed ID: 25810335 [No Abstract] [Full Text] [Related]
7. [The GISSI-HF trial]. Tavazzi L, Nodari S. G Ital Cardiol (Rome); 2009 Mar 28; 10(3):129-34. PubMed ID: 19385306 [No Abstract] [Full Text] [Related]
8. Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure. Capurso C, Solfrizzi V, D'Introno A, Colacicco AM, Gadaleta A, Frisardi V, Santamato A, Capurso A, Panza F. J Am Geriatr Soc; 2008 Jul 28; 56(7):1366-7. PubMed ID: 18774975 [No Abstract] [Full Text] [Related]
9. Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure. Krum H, Ashton E, Reid C, Kalff V, Rogers J, Amarena J, Singh B, Tonkin A. J Card Fail; 2007 Feb 28; 13(1):1-7. PubMed ID: 17338996 [Abstract] [Full Text] [Related]
10. Statins for ischemic systolic heart failure. Masoudi FA. N Engl J Med; 2007 Nov 29; 357(22):2301-4. PubMed ID: 17984167 [No Abstract] [Full Text] [Related]
11. CORONA--rosuvastatin in older patients with systolic heart failure. Jackson G. Int J Clin Pract; 2008 Jan 29; 62(1):1. PubMed ID: 18173807 [No Abstract] [Full Text] [Related]
13. Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.". Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ. Circulation; 2015 Dec 01; 132(22):e358. PubMed ID: 26621661 [No Abstract] [Full Text] [Related]
14. Letter by Lin et al Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.". Lin GM, Hung Y, Li YH. Circulation; 2015 Dec 01; 132(22):e357. PubMed ID: 26621660 [No Abstract] [Full Text] [Related]
15. Low coenzyme Q₁₀ levels and the outcome of statin treatment in heart failure. Mortensen SA. J Am Coll Cardiol; 2011 Apr 05; 57(14):1569; author reply 1569. PubMed ID: 21453843 [No Abstract] [Full Text] [Related]
16. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure). McMurray JJ, Dunselman P, Wedel H, Cleland JG, Lindberg M, Hjalmarson A, Kjekshus J, Waagstein F, Apetrei E, Barrios V, Böhm M, Kamenský G, Komajda M, Mareev V, Wikstrand J, CORONA Study Group. J Am Coll Cardiol; 2010 Oct 05; 56(15):1196-204. PubMed ID: 20883926 [Abstract] [Full Text] [Related]
17. CORONA study highlights challenges of treating older patients with systolic heart failure. Cardiovasc J Afr; 2007 Oct 05; 18(6):402-4. PubMed ID: 18092121 [No Abstract] [Full Text] [Related]
18. Interpretation of amino-terminal pro-brain natriuretic peptide levels in the HPS and the CORONA study. Cleland JG, Squire I, Ng L. J Am Coll Cardiol; 2008 Sep 23; 52(13):1104-5. PubMed ID: 18848145 [No Abstract] [Full Text] [Related]
19. [The role of statins in the treatment of heart failure]. Eren M. Turk Kardiyol Dern Ars; 2009 Oct 23; 37(7):501-11. PubMed ID: 20098048 [Abstract] [Full Text] [Related]
20. Atorvastatin, not rosuvastatin, improves cardiac function in heart failure: a meta-analysis of randomized trials. Takagi H, Umemoto T. Int J Cardiol; 2012 Mar 08; 155(2):296-9. PubMed ID: 22200185 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]